274 related articles for article (PubMed ID: 7419650)
21. Pharmacokinetics of phenylbutazone and its metabolites in the horse.
Gerring EL; Lees P; Taylor JB
Equine Vet J; 1981 Jul; 13(3):152-7. PubMed ID: 7297544
[TBL] [Abstract][Full Text] [Related]
22. GLC determination of gamma-hydroxyphenylbutazone in plasma.
Midha KK; McGilveray IJ; Charette C
J Pharm Sci; 1974 Nov; 63(11):1751-4. PubMed ID: 4427237
[No Abstract] [Full Text] [Related]
23. Simultaneous analysis of flunixin, naproxen, ethacrynic acid, indomethacin, phenylbutazone, mefenamic acid and thiosalicylic acid in plasma and urine by high-performance liquid chromatography and gas chromatography-mass spectrometry.
Singh AK; Jang Y; Mishra U; Granley K
J Chromatogr; 1991 Aug; 568(2):351-61. PubMed ID: 1783641
[TBL] [Abstract][Full Text] [Related]
24. Detection of phenylbutazone and oxyphenbutazone in the urine of thoroughbreds.
Finocchio EJ; Ozog FJ; Oehme FW; Johnson JH; Osbaldiston GW
J Am Vet Med Assoc; 1970 Feb; 156(4):454-6. PubMed ID: 5414171
[No Abstract] [Full Text] [Related]
25. [Determination of feprazone and one of its metabolites in human plasma after high-performance liquid chromatographic or thin-layer chromatographic separation].
Spahn H; Mutschler E
J Chromatogr; 1982 Oct; 232(1):145-53. PubMed ID: 7142323
[TBL] [Abstract][Full Text] [Related]
26. Separation of furosemide, phenylbutazone and oxyphenbutazone in plasma by direct injection onto internal surface reversed-phase columns with systematic optimization of selectivity.
Pinkerton TC; Perry JA; Rateike JD
J Chromatogr; 1986 Oct; 367(2):412-8. PubMed ID: 3782354
[No Abstract] [Full Text] [Related]
27. The assay of phenylbutazone in human plasma by a specific and sensitive gas-liquid chromatographic procedure.
McGilveray IJ; Midha KK; Brien R; Wilson L
J Chromatogr; 1974 Feb; 89(1):17-22. PubMed ID: 4815964
[No Abstract] [Full Text] [Related]
28. Pharmacokinetics of intravenous and intragastric cimetidine in horses. I. Effects of intravenous cimetidine on pharmacokinetics of intravenous phenylbutazone.
Sams RA; Gerken DF; Dyke TM; Reed SM; Ashcraft SM
J Vet Pharmacol Ther; 1997 Oct; 20(5):355-61. PubMed ID: 9350255
[TBL] [Abstract][Full Text] [Related]
29. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
[TBL] [Abstract][Full Text] [Related]
30. GLC determination of plasma concentration of phenylbutazone and its metabolite oxyphenbutazone.
Midha KK; McGilveray IJ; Charette C
J Pharm Sci; 1974 Aug; 63(8):1234-9. PubMed ID: 4852201
[No Abstract] [Full Text] [Related]
31. Effects of phenylbutazone and oxyphenbutazone on basic drug detection in high performance thin layer chromatographic systems.
Woods WE; Chay S; Houston T; Blake JW; Tobin T
J Vet Pharmacol Ther; 1985 Jun; 8(2):181-9. PubMed ID: 2862290
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of bumadizone-, phenylbutazone- and oxyphenbutazone-plasma levels after a single oral dose of phenylbutazone and of bumadizone, respectively (author's transl)].
Spahn H; Mutschler E; Geissler HE; Faust-Tinnefeldt G
Arzneimittelforschung; 1981; 31(3):499-503. PubMed ID: 6894380
[TBL] [Abstract][Full Text] [Related]
33. The effect of inflammation on the disposition of phenylbutazone in thoroughbred horses.
Mills PC; Ng JC; Auer DE
J Vet Pharmacol Ther; 1996 Dec; 19(6):475-81. PubMed ID: 8971677
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of phenylbutazone in two age groups of ponies: a preliminary study.
Lees P; Maitho TE; Taylor JB
Vet Rec; 1985 Mar; 116(9):229-32. PubMed ID: 4002593
[TBL] [Abstract][Full Text] [Related]
35. Determination of non-protein bound phenylbutazone in bovine plasma using ultrafiltration and liquid chromatography with ultraviolet detection.
De Veau EJ
J Chromatogr B Biomed Sci Appl; 1999 Jan; 721(1):141-5. PubMed ID: 10027645
[TBL] [Abstract][Full Text] [Related]
36. High-performance liquid chromatographic determination of sulfinpyrazone and its metabolites in plasma.
Kuo BS; Kaplan LA; Ritschel WA
Arzneimittelforschung; 1984; 34(5):548-50. PubMed ID: 6540568
[TBL] [Abstract][Full Text] [Related]
37. Quantitative analysis of minaprine and some of its metabolites with application to kinetic studies in rats.
Fong MH; Abbiati A; Benfenati E; Caccia S
J Chromatogr; 1983 Mar; 259(1):141-9. PubMed ID: 6853632
[TBL] [Abstract][Full Text] [Related]
38. Determination of mofebutazone and its 4-hydroxy metabolite in plasma and urine by high-performance liquid chromatography.
Delbeke FT; Debackere M
J Chromatogr; 1986 Nov; 369(2):440-4. PubMed ID: 3805210
[No Abstract] [Full Text] [Related]
39. Disposition and tolerance of suxibuzone in horses.
Jaraiz MV; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
Equine Vet J; 1999 Sep; 31(5):411-6. PubMed ID: 10505957
[TBL] [Abstract][Full Text] [Related]
40. High-performance liquid chromatographic determination of new 2,3-benzodiazepines.
Rizzo M; Sinopoli VA; Gitto R; Zappalà M; De Sarro G; Chimirri A
J Chromatogr B Biomed Sci Appl; 1998 Jan; 705(1):149-53. PubMed ID: 9498683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
